Loading…

Hepatic adenomatosis associated with hormone replacement therapy and hemosiderosis: A case report

We have reported a case of hepatic adenomatosis associated with hormone replacement therapy (estrogen and progesterone) and hemosiderosis caused by excessive blood transfusion for the treatment of chronic myeloid leukemia. A 34-year-old woman was found to have several hepatic tumors on a routine med...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG 2006-01, Vol.12 (4), p.652-655
Main Authors: Hagiwara, Satoshi, Takagi, Hitoshi, Kanda, Daisuke, Sohara, Naondo, Kakizaki, Satoru, Katakai, Kenji, Yoshinaga, Teruo, Higuchi, Tsugio, Nomoto, Kenichi, Kuwano, Hiroyuki, Mori, Masatomo
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have reported a case of hepatic adenomatosis associated with hormone replacement therapy (estrogen and progesterone) and hemosiderosis caused by excessive blood transfusion for the treatment of chronic myeloid leukemia. A 34-year-old woman was found to have several hepatic tumors on a routine medical examination. The general condition was good. Laboratory studies showed iron overload. Abdominal computed tomography and selective hepatic angiography showed several hypervascular tumors in the right lobe of the liver (up to 20 mm in diameter). Since hepatocellular carcinoma could not be ruled out, subsegmental hepatectomy was performed. Histopathological examination of the surgical specimen showed hepatic adenomatosis with hemosiderosis. Both hormone replacement therapy and iron overload could be the cause of hepatic adenomatosis.
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v12.i4.652